Compugen Ltd. (CGEN) is a pioneering clinical-stage biotechnology firm dedicated to developing innovative therapeutics for cancer and autoimmune disorders. Utilizing its advanced computational discovery platform, the company is actively advancing a diverse pipeline of immuno-oncology candidates that target critical pathways in the tumor microenvironment. Headquartered in Holon, Israel, Compugen is well-positioned to capitalize on international opportunities, particularly in the U.S. and Europe, as it seeks to transform treatment paradigms and improve patient outcomes in oncology and related therapeutic areas.
Click "Analyze" to generate stock analysis
CGEN Price Trend and Signals
CGEN Option Volumes & Open Interests (aggregated)
CGEN Put Call Ratios and IV (aggregated)
CGEN Financials
2025-10-21Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-10-13Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-13Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-13Bullishprice_signal
Large price change detected: 21.08%.
2025-10-09Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-01Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-01Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-01Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-01Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.